Analyst Ratings for Pharming Group (PHAR)

PHAR Rating Summary

PHAR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PHAR
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $38.00 (+182.1%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/10/2026 Canaccord Whitney Ijem New Coverage Buy
(N/A)
37.00
(N/A)
16.98
(13.47)
-20.67% Details
12/9/2024 Jefferies Lucy Codrington New Coverage Buy
(N/A)
14.00
(N/A)
7.56
(13.47)
78.17% Details